MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units (0053L0.KQ) Price

MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units is offered by Tiger ETF, a leading player in the field of passive investments.

The ISIN of MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units is KR70053L0005.

The total expense ratio of MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units is 0.49%, which means that investors pay 49.00 KRW per 10,000 KRW in investment capital annually.

The ETF is listed in KRW.

European investors may incur additional costs for currency exchange and transaction fees.

No, MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units does not comply with the EU UCITS investor protection directives.

The P/E ratio of MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units is 34.31.

MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units tracks the performance of the Mirae Asset China Humanoid Robot Index - CNH - Benchmark Price Return.

MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units is domiciled in KR.

The fund was launched on 5/27/2025.

The MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units mainly invests in Topic companies.

The NAV of MIRAE ASSET TIGER CHINA HUMANOID ROBOT ETF Units amounts to 11.87 B KRW.

The price-to-book ratio is 4.42.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.